Galmed Pharmaceuticals (GLMD) Receivables - Net (2013 - 2024)
Galmed Pharmaceuticals (GLMD) posted quarterly Receivables - Net of $672000.0 for Q4 2024, up 40.0% year-over-year from $480000.0 in Q1 2024, and up 40.0% quarter-over-quarter from $480000.0 in Q4 2023.
Galmed Pharmaceuticals (GLMD) Receivables - Net (2013 - 2024) Analysis & Trends
Galmed Pharmaceuticals' Receivables - Net history runs 12 years deep, the most recent figure standing at $672000.0 for Q4 2024.
- In Q4 2024, Receivables - Net rose 40.0% year-over-year to $672000.0; the TTM figure through Dec 2024 stood at $672000.0 (up 40.0% YoY), while the FY2024 annual figure was $672000.0, up 40.0% from the prior year.
- Receivables - Net for Q4 2024 stood at $672000.0, up from $480000.0 in the prior quarter.
- The five-year high for Receivables - Net was $1.1 million in Q4 2021, with the low at $480000.0 in Q4 2023.
- The 5-year median for Receivables - Net is $742000.0 (2020), against an average of $763833.3.
- The sharpest annual moves came in 2023 and 2024: Receivables - Net sank 41.82% in 2023, then soared 40.0% in 2024.
- Galmed Pharmaceuticals' Receivables - Net stood at $812000.0 in 2020, then surged by 38.55% to $1.1 million in 2021, then fell by 26.67% to $825000.0 in 2022, then slumped by 41.82% to $480000.0 in 2023, then jumped by 40.0% to $672000.0 in 2024.
- Business Quant data shows GLMD's Receivables - Net at $672000.0 in Q4 2024, $480000.0 in Q4 2023, and $825000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Galmed Pharmaceuticals | 2.39 Mn | -9.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 672,000.00 |
| Dec 31, 2024 | 672,000.00 |
| Dec 31, 2023 | 480,000.00 |
| Dec 31, 2023 | 480,000.00 |
| Dec 31, 2022 | 825,000.00 |
| Dec 31, 2022 | 825,000.00 |
| Dec 31, 2021 | 1.13 Mn |
| Dec 31, 2021 | 1.13 Mn |
| Dec 31, 2020 | 812,000.00 |
| Dec 31, 2020 | 812,000.00 |
| Jun 30, 2020 | 669,000.00 |
| Jun 30, 2020 | 669,000.00 |
| Dec 31, 2019 | 827,000.00 |
| Dec 31, 2019 | 827,000.00 |
| Jun 30, 2019 | 705,000.00 |
| Jun 30, 2019 | 705,000.00 |
| Dec 31, 2018 | 218,000.00 |
| Dec 31, 2018 | 218,000.00 |
| Jun 30, 2018 | 368,000.00 |
| Jun 30, 2018 | 368,000.00 |